Results 251 to 260 of about 2,352,522 (319)

Engineering tandem VHHs to target different epitopes to enhance antibody‐dependent cell‐mediated cytotoxicity

open access: yesFEBS Open Bio, EarlyView.
Tandem VHH targeting distinct EGFR epitopes were engineered into a monovalent bispecific antibody (7D12‐EGA1‐Fc) with more potent ADCC without increasing affinity to EGFR. Structural modeling of 7D12‐EGA1‐Fc showed cross‐linking of separate EGFR domains to enhance CD16a engagement on NK cells.
Yuqiang Xu   +5 more
wiley   +1 more source

Red cell indices as predictors of cancer risk: findings from a large prospective cohort study. [PDF]

open access: yesBMC Cancer
Fu C   +10 more
europepmc   +1 more source

Amustaline/glutathione pathogen-reduced red cell hemoglobin utilization in complex cardiac surgery: A post hoc analysis of the phase 3 ReCePI trial. [PDF]

open access: yesTransfusion
Welsby IJ   +11 more
europepmc   +1 more source

Red Cell Polyagglutination

Transfusion Medicine Reviews, 1988
OLYAGGLUTINATION has been recognized since the beginning of the century. In this condition, altered human RBCs are agglutinated by a large percentage of compatible sera from healthy human adults, but not usually by their own serum or those from cord blood.
C, Levene   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy